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Between the atrial lumen and the pericardial space are transmural pathways, and movement of interstitial fluid (ISF) through these pathways is one of the main driving forces regulating translocation of substances from the interstitium into the blood. To define how ISF translocation from the interstitial space into the luminal space is regulated by each component of atrial hemodynamics, we devised a new rabbit atrial model in which each physical parameter could be controlled independently. Using this system, we also defined the physiological role of the cardiac Na ϩ /Ca 2ϩ exchanger on secretion of atrial natriuretic peptide (ANP) by depletion of extracellular Na ϩ ([Na ϩ ]o). Increases in stroke volume and atrial end-systolic volume increased ISF translocation and ANP secretion. However, an increase in atrial rate did not influence ISF translocation but, rather, increased ANP secretion. Gradual depletion of [Na ϩ ]o caused gradual increases in ANP secretion and intracellular Ca 2ϩ ([Ca 2ϩ ]i), which were blocked in the presence of Ca 2ϩ -free buffer and Ni 2ϩ , but not in the presence of KB-R7943, diltiazem, mibefradil, caffeine, or monensin. Amiloride and its analog blocked an increase in ANP secretion but not an increase in [Ca 2ϩ ]i by [Na ϩ ]o depletion. Therefore, we suggest that ANP secretion and ISF translocation may be differently controlled by each physical factor. These results also suggest that the increase in ANP secretion in response to [ space and blood depends on the balance of hydraulic and oncotic pressures between these compartments. The hydraulic pressure caused by the continuous beating of the heart exerts a dynamic pressure on the interstitial space, and this pressure is dependent on myocardial hemodynamics. It is well known that the heart maintains its water content within a narrow critical range. The heart is supplied by a rich lymphatic network, and the interstitial fluid (ISF) of the heart is washed down directly into the atrial lumen. Therefore, the interstitial space is an important route for the regulation of interstitium, venous flow, and lymphatics. We have reported the existence of transmural pathways between the atrial lumen and the pericardial space (5) . ISF movement through these pathways is one of the main driving forces in the secretion of atrial natriuretic peptide (ANP) from the interstitial space into the atrial lumen (5). Various models have been proposed for fluid transport in the myocardium, but some questions remain unanswered (5). It is uncertain how ISF translocation from the interstitial space into the luminal space is regulated by each component of atrial hemodynamics. Using isolated perfused rabbit atria, we developed a new method whereby specific physical parameters, such as atrial rate, stroke volume (SV), and atrial end-systolic volume (AESV), can be controlled. Using this perfusion model, we attempted to elucidate the role of each physical parameter on the translocation of ISF and ANP.
In cardiac muscle cells, three primary transport systems are responsible for intracellular Ca 2ϩ homeostasis (2, 11, 24) . In particular, the Na ϩ /Ca 2ϩ exchanger (NCX) is the primary mechanism responsible for removing Ca 2ϩ from the cells (17) . The NCX can function in "forward mode" or "reverse mode" (15) . The direction of this transport is governed by the magnitude and orientation of the transmembrane electrical and chemical gradients for Na ϩ and Ca 2ϩ (17) . NCX activity directly influences intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), which causes cardiac hemodynamic change followed by the secretion of ANP. However, the effect of [Ca 2ϩ ] i on ANP secretion is controversial, despite extensive studies (6, 9, 14, (19) (20) (21) 
MATERIALS AND METHODS

Animals
New Zealand White rabbits, weighing ϳ1.5 kg, were used. All animal experimentation was conducted in accord with the American Association for the Accreditation of Laboratory Animal Care (1).
Isolated Perfused Atrial Preparation
New Zealand White rabbits were anesthetized with thiopental sodium and killed by exsanguination. A perfusion catheter was inserted into the atrium by a method described previously, with some modifications (5, 7, 23) . Briefly, the heart was rapidly removed and placed in oxygenated saline. The right atrium was dissected along the tricuspid valve annulus, and then the area above the sinoatrial node was cut away. A double-barreled cannula (5 mm OD, 4 mm ID) was inserted into the atrium and secured with ligatures. The inner barrel (1.5 mm ID) was used for outflow, and the outer barrel was used for inflow of perfusate. The cannulated atrium was immediately transferred and fitted into a constant-temperature (36°C) organ chamber containing HEPES buffer (118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 10 mM HEPES, 10 mM glucose, and 0.1% BSA). Air bubbles trapped in the pericardial space were removed through polyethylene tubing located on the water-tight silicone rubber cap of the organ chamber. Atrial luminal and pericardial pressures were recorded on a physiograph (model MK IV, Narco Bio-Systems, Houston, TX) via a pressure transducer throughout the experiment. Perfusate was continuously oxygenated and infused into the atrial lumen with a peristaltic pump. The chamber space was oxygenated through silicone tubing coils located inside the organ chamber.
Control of Physical Parameters
The experimental system was made by some modifications of our nonbeating model (8, 23 ) and consisted of three major components: a perfusion system, a rate control unit, and an SV control unit (Fig. 1) . The circular movement of the motor (Con-Torque, Eberbach, Ann Arbor, MI) was converted to the linear movement of the SV syringe through a ball joint. The chamber space was completely closed, except for the connection to the SV control unit. Thus the repetitive, push-andpull motion of chamber fluid generated a positive-and-negative transmural pressure, which caused passive, cyclic changes in atrial volume. The amount of SV was regulated by adjusting distance. One rotation of the adjustment knob of the SV control motor was 15 l of SV. Flow through the atrial lumen was maintained only in the forward direction by placing one-way check balls on inflow and outflow lines. Basal distension of the atrium (AESV) was adjusted by pulland-fix of chamber fluid by means of an AESV syringe.
Experimental Protocols
The atria were perfused for 30 min to stabilize ANP secretion and equilibrate the extracellular space with a marker at a steady state. 51 Cr-EDTA (10 Ci/ml) was introduced into the pericardial fluid.
Protocol 1: effect of SV on ISF translocation and ANP secretion. SV was changed from 65 to 110 and 150 l/cycle for 10 min in a stepwise pattern and returned to 65 l/cycle. AESV was fixed at 0 l for all atria used in this protocol. Thus the ejection fraction (EF) was always 100%, and the atrial end-diastolic volume (AEDV) was the same as SV. Atrial rate was fixed at 30 cycles/min (AR30).
Protocol 2: effect of basal volume (AESV) on ISF translocation and ANP secretion. SV was fixed at 60 l for all atria used in this protocol, and AESV was increased from 0 l to 55 and 110 l by withdrawal of pericardial fluid using the AESV syringe. AESV/AEDV changed from 0/60 l (EF ϭ 100%), 55/115 l (EF ϭ 52.2%), and 110/170 l (EF ϭ 35.3%) for 10 min in a stepwise pattern and returned to 0/60 l. Atrial output was constant, because atrial rate (AR30) and SV (60 l) were fixed.
Protocol 3: effect of atrial rate on ISF translocation and ANP secretion. Atrial rate was changed from 30 to 60, 120, 200, and 280 cycles/min for 10 min in a stepwise pattern and returned to AR30 to check the effect of the time sequence of the experiments. In some experiments, the order of changing atrial rate was performed downward to rule out changes due to the order of changes on the atrial rate. The other parameters were fixed as follows: SV ϭ 65 l, AESV ϭ 0 l, and AEDV ϭ 65 l.
Protocol 4: effect of Na ϩ depletion on ANP secretion. Atrial rate and AESV were fixed at 23 cycles/min and 0 l, respectively. SV was gradually increased from 50 to 100 and 200 l, respectively. In another protocol, SV was also fixed at 100 l. To determine the effect of NCX on ANP secretion, the Na ϩ gradient between the extracellular and intracellular space was gradually decreased by extracellular Na ϩ depletion. Nmethyl-D-glucamine (NMG) or LiCl was used instead of NaCl. The atrium was perfused with HEPES buffer containing 140 mM [Na ϩ ]o and stabilized for 30 min. A sample was collected every 2 min for 10 min as a control, and then the buffer on the luminal and pericardial sides was changed to HEPES buffer containing 70 mM [Na ϩ ]o. After 10 min of stabilization, samples were collected for 10 min, and then buffer was continuously changed to HEPES buffer containing 28, 14, and 0 mM [Na ϩ ]o, continuing the same protocol as above. To test the effect on Na ϩ depletion-induced ANP secretion, samples were pretreated with KR-B7943 (10
Measurement of ISF Translocation
To estimate ISF translocation, the transmural atrial clearance of 51 Cr-EDTA was measured with a gamma counting system (Auto Gamma 500 C, Packard, Downers Grove, IL), as described previously (5). Radioactivity in the atrial perfusate and pericardial buffer solution was measured, and the amount of ISF translocated through the atrial wall was calculated as follows
total radioactivity in perfusate (cpm/min) ϫ 1,000 radioactivity in pericardial reservoir (cpm/l) ϫ atrial wet wt (mg)
Total ISF translocation was expressed as microliters of ISF per gram of tissue per minute after calculation of ISF translocated by measuring 51 Cr-EDTA in perfusate for every 2-min fraction.
Radioimmunoassay of Immunoreactive ANP
Immunoreactive ANP in the perfusate was directly measured by radioimmunoassay, as described previously (5) . The radioimmunoassay was performed on the same day of the experiment, and all samples in an experiment were analyzed in a single assay. Nonspecific binding was Ͻ3%. The 50% intercept was at 26.6 Ϯ 2.9 pg/tube. The molar concentrations of immunoreactive ANP released were calculated as follows
Measurement of [Ca 2ϩ ]i in Single Atrial Myocytes
Single atrial myocytes were isolated according to a previously described technique with minor modifications (18) . Changes in the [Ca 2ϩ ]i of single atrial myocytes were measured with a fluorescence digital imaging microscopy system (Atto Instruments, Rockville, MD), as described elsewhere (18) . Isolated myocytes were incubated in HEPES buffer containing 2 M fura 2-AM (Molecular Probes, Eugene, OR) and 0.02% Pluronic F-127 (Molecular Probes) for 20 min at room temperature and then washed with fresh HEPES buffer to remove extracellular dye. Cells were attached on a perfusion chamber coated with matrix gel and placed on the stage of an inverted fluorescence microscope (Axiovert 135, Karl Zeiss, Jena, Germany) attached to an Attofluor digital fluorescence microscopy system. Cells were stimulated at 1 Hz (60 V for 0.6 ms) and perfused with HEPES buffer containing 1 mM Ca 2ϩ for 5 min at 0.7 ml/min. Buffer was changed to Na ϩ -depleted HEPES buffer. Cells were imaged with excitation wavelengths of 338 and 380 nm and an emission wavelength of 520 nm. The fluorescence images were captured with an intensified charge-coupled device camera and analyzed with Attofluor image processing software. Changes in [Ca 2ϩ ]i are presented as a ratio of fluorescence at 340 nm to fluorescence at 380 nm. Background was subtracted. Experiments were performed at room temperature.
Statistical Analysis
Values are means Ϯ SE. Statistical assessment of the data was made by Student's t-test or ANOVA followed by Duncan's multiple range test when appropriate. Linear regressions were calculated by the least-squares method. P Ͻ 0.05 was taken as significant.
RESULTS
Effect of SV on ISF Translocation and ANP Secretion
To evaluate the effect of SV on ISF translocation and ANP secretion, SV was changed from 65 to 110 and 150 l/cycle at fixed atrial rate (AR30) and AESV (0 l/ cycle; Fig. 2A ; n ϭ 6). When SV was increased from 65 to 150 l/cycle and returned to 65 l/cycle, ANP secretion and ISF translocation were proportionately increased and returned to basal level. Figure 2B (top) shows the average of each parameter in terms of SV. The ISF translocation and ANP secretion increased in proportion to SV. Therefore, ISF ANP concentration, which represents the release rate of ANP from atrial myocytes, was increased by increasing SV from 65 to 110 l/cycle.
To evaluate possible differences of ISF response to SV at different atrial rates, we performed two additional series of experiments at AR30 and 180 cycles/ min (AR180). There were no significant differences in ISF translocation between AR30 and AR180 (45.18 Ϯ 6.98 vs. 39.11 Ϯ 14.24 l/min at 65 l/cycle, n ϭ 6). However, ANP secretion was significantly higher at AR180 than that at AR30 (179.09 Ϯ 29.17 vs. 54.08 Ϯ 7.74 pg/min at 65 l/cycle, P Ͻ 0.001). Figure 2B (bottom) shows the comparison of responsiveness of ISF translocation and ANP secretion in terms of SV between AR30 and AR180. The response of ISF translocation to low SV was similar in both groups, but the response to higher SV was accentuated at AR180. However, the response of ANP secretion to SV was markedly attenuated at AR180.
Effect of AESV on ISF Translocation and ANP Secretion
In these experiments, AESV/AEDV was changed from 0/60 l (EF ϭ 100%), 55/115 l (EF ϭ 52.2%), and 110/170 l (EF ϭ 35.3%) at fixed SV (65 l/cycle) and atrial rate (AR30, n ϭ 6). Therefore, atrial output was maintained constantly. When AESV was increased from 0 to 55 l, neither ISF translocation nor ANP secretion changed (Fig. 3) . By increasing AESV from 55 to 110 l, ISF translocation and ANP secretion increased significantly. When AESV was decreased from 110 to 0 l, ISF translocation and ANP secretion increased markedly, but ANP concentration did not change (fraction 16 in Fig. 3A) . The response of ISF translocation and ANP secretion to AESV at AR180 (n ϭ 6) was similar to that at AR30 (Fig. 3B, bottom) . 
Effect of Atrial Rate on ISF Translocation and ANP Secretion
Surprisingly, total ISF translocation remained relatively constant over the range of atrial rates. ANP secretion was markedly increased from AR30 to 120 cycles/min and then increased slowly ( Fig. 4; n ϭ 6 ). Rate dependency is more prominent in ANP secretion than in ISF translocation. Therefore, ISF ANP concentration gradually increased with increasing atrial rate and reached a peak at 120 cycles/min. Figure 5 shows the relationship between atrial output, ANP secretion, and ISF translocation in groups with changing SV and atrial rate. Atrial output was obtained by multiplying SV by atrial rate. Atrial output is positively correlated with ANP secretion in the SV-changed group ( Fig. 5A ; y ϭ 4.76x ϩ 235, r ϭ 0.55, P Ͻ 0.001) and the atrial rate-changed group (y ϭ 7.34x ϩ 126.12, r ϭ 0.79, P Ͻ 0.001). A positive correlation between atrial rate and ISF translocation was observed in the SVchanged group ( Fig. 5B ; y ϭ 1.72x ϩ 35.5, r ϭ 0.49, P Ͻ 0.05) but not in the atrial rate-changed group (y ϭ 1.25x ϩ 60.9, r ϭ 0.3, P ϭ 0.2). There were also close relationships between extracellular fluid translocation and ANP secretion in both groups (Fig. 5C) . Fig. 3 . Effect of AESV on ISF translocation and ANP release. A: by increasing AESV to 110 l at fixed SV and atrial rate, ISF translocation and ANP secretion increased. B: average of ANP secretion and ISF translocation in terms of AESV at fixed atrial rate (AR30; top) and ANP secretion and ISF translocation in terms of AESV at AR30 and AR180 (bottom). AESV was adjusted to 0, 55, and 110 l, and then ejection fraction (ratio of AESV to atrial end-diastolic volume) became 100%, 52.2%, and 35.3%, respectively. ISF translocation and ANP secretion were increased by increasing AESV to 110 l. Response to ISF translocation and ANP secretion by changing AESV was similar for AR30 and AR180. ** Significantly different from corresponding value, P Ͻ 0.01.
Effect of Gradual Decreases in [Na ϩ ] o on ANP Secretion
To determine the effect of NCX on ANP secretion using this model, [Na ϩ ] o was decreased from 140 to 0 mM at fixed atrial rate (23 cycles/min) and AESV (0 l/cycle), while SV was gradually increased from 50 to 100 and 200 l (Fig. 6A) . ANP secretion was markedly increased by the replacement of extracellular Na ϩ with NMG; ANP was particularly accentuated at higher SV (n ϭ 9). An increase in ANP secretion by Na ϩ replacement with NMG was similar to that by Na ϩ replacement with Li ϩ ( Fig. 6B ; n ϭ 10). This effect was blocked by Ca 2ϩ -free conditions ( Fig. 6B ; n ϭ 5), but not by pretreatment with mibefradil (10 Ϫ5 M, n ϭ 8) or diltiazem (10 Ϫ6 M, n ϭ 5; Fig. 6C ). [Na ϩ ] o was gradually decreased from 140 to 70, 28, 14, and 0 mM at fixed atrial rate (23 cycles/min), SV (100 l/cycle), and AESV (0 l/cycle), and ANP secretion was measured (Fig. 7A) . We also measured the ratio of increase in ANP secretion by Na ϩ depletion to 140 mM [Na ϩ ] o (Fig. 7B) . The secretion of ANP was markedly increased by decreasing [Na (Fig. 7B) .
To define the mechanism involved in [Na ϩ ] o depletion-induced ANP secretion, we used KB-R7943 and ] i in single beating Fig. 4 . Effect of atrial rate on ISF translocation and ANP secretion. SV (55 l) and AESV (0 l) were fixed. ANP secretion was markedly increased by increasing atrial rate to 120 cycles/min. At higher atrial rates, ANP increased slowly. ISF translocation did not change significantly. Significantly different from corresponding value: * P Ͻ 0.05 and ** P Ͻ 0.01. (Fig. 8B ).
Effect of Gradual Decreases in [Na
DISCUSSION
The myocardial interstitium plays an important role in the regulation of cardiac function under physiological and pathological conditions. It is believed that exchanges of substances between atrial tissue and blood are dependent on their metabolic rates and the transport rate of ISF. Using a new experimental model that can control the physical parameters of atrial hemodynamics, we showed that the translocation of ISF from atrial tissue is differently regulated by each physical factor. The translocation of ISF increased more by increasing SV than by increasing atrial rate or basal volume. Interestingly, the translocation of ISF was maintained relatively constant across the range of atrial rates by abruptly decreasing the amount of ISF translocation in each cycle. The maintenance of total ISF translocation, regardless of atrial rates, appears to be the ideal way for the atrium to maintain a constant interstitial environment. However, ISF translocation in terms of SV was decreased by increasing SV, similar to ISF translocation in terms of atrial rate by increasing atrial rate. These decrements caused an attenuation of total ISF translocation per unit time by changing SV and atrial rate. These results suggest that total ISF movement across the atrial wall through paracellular pathways may be more dependent on cardiac output than on atrial rate or SV.
Degrees of contraction (AESV) and distension (AEDV) of atrial muscles are different in physiological and pathological conditions of the heart. The contraction of cardiac muscle is severely disturbed in the distended atrium of congestive heart failure. There was no accumulation of atrial ISF when atria were working with 100% EF, but significant amounts of ISF accumulated in the interstitial space when EF was severely disturbed. This stagnated ISF was translocated into the atrial lumen by the release of basal volume distension (shortening of muscle length), as clearly shown in fraction 16 of Fig. 3A . The accumulation of ISF by atrial distension was dependent on the degree of distension volume (2, 24) , but not on the duration of distension. These data suggest that significant amounts of metabolites may accumulate in the ISF during atrial fibrillation or congestive heart failure, where atria are severely distended and SV is decreased SV (decreased EF). These metabolites may further aggravate atrial function. Our data clearly show that changes of muscle length and frequency play a unique role in ISF translocation during atrial cycles. It is not clear whether paracellular pathways in cardiac atria are important for the exchange of molecules through ISF translocation.
The patterns of ANP release observed in this model provided interesting facts about the exchange patterns of molecules between atrial tissue and blood. First, ANP molecules are released from myocytes into the interstitial space in a unique pattern by each physical factor, and then these molecules are transported into the atrial lumen concomitantly with unique patterns of ISF translocation for each physical factor (5) . One example is the relationship between heart rate and plasma ANP concentration. Tachycardia generally raises plasma ANP concentration (18, 22) , but this relationship was not linear over all ranges of heart rate and showed a significantly blunted response at higher heart rate. There are many hypotheses related to blunted response of increased plasma ANP to heart rate, such as depressed secretion from myocytes, increased metabolism, and concomitant changes of other physical parameters that can inhibit ANP secretion. Our study clearly showed that a lesser increase in plasma ANP in tachycardia resulted from the function of unique characteristics of ANP release from myocytes and of ISF regulation by atrial rate. Patterns of decreasing unit ISF translocation caused by atrial rate and SV resulted in a lower release of total ANP into the atrial lumen. The amounts of ANP secreted into the atrial lumen may show linear patterns if unit ISF translocation was not decreased. This means that plasma ANP concentration is under fine control by each hemodynamic factor. This fine control provides maximum response when atrial rate and SV are increased (e.g., exercise), moderate response when only one factor is increased (e.g., palpitation), and minimal response when one factor is increased but the other is decreased (e.g., hemorrhagic hypotension). Therefore, we believe that this kind of ANP regulation may help atria differentiate various stimuli and may help properly regulate the body fluid through the blood vessels and kidneys.
Using this model to characterize the physiological role of cardiac NCX on ANP secretion, we studied the effects of gradual decreases in [ depletion-induced increase in ANP secretion. We expected that monensin would cause a decreased Na ϩ gradient followed by inhibition of NCX activity, whereas amiloride may cause an increased Na ϩ gradient followed by activation of NCX activity. However, monensin did not influence NCX activity. It has been reported that intracellular acidification clearly inhibits outward NCX current in guinea pig ventricular myocytes (10) . Therefore, we suggest that MIA or amiloride may inhibit NCX activity by intracellular acidification through the inhibition of NHX activity.
A In conclusion, we believe that this model may provide many benefits in the study of the mechanism of atrial ANP secretion and ISF translocation. These results also suggest that the increase in ANP secretion in response to [Na ϩ ] o depletion may partly involve inhibition of the NCX and NHX but may not involve an increase in [Ca 2ϩ ] i .
